PIK3CG Is a Potential Therapeutic Target in Androgen Receptor–Indifferent Metastatic Prostate Cancer

Wen-Cheng Chung(University of Mississippi Medical Center), Keli Xu(University of Mississippi Medical Center)
American Journal Of Pathology
August 14, 2020
Cited by 20


Related Papers